News Room

  • September 6, 2018
    Dr. William J. Foster Joins Altasciences as Principal Investigator
    Altasciences is pleased to welcome Dr. William J. Foster, MD, PhD, FRCSC, to the Altasciences family as Principal Investigator and Consultant on clinical trials.
  • August 20, 2018
    Altasciences Initiates Expansion of Bioanalytical Laboratory
    Altasciences announced today that construction work has begun on the expansion of their ligand binding laboratory to meet the high demand for quality bioanalytical services.
  • August 15, 2018
    Altasciences to Acquire Preclinical Safety Testing Services
    Altasciences announced today that it has signed a definitive agreement to acquire the preclinical testing business of SNBL U.S.A.
  • August 8, 2018
    Altasciences’ Chris Perkin Honored as One of 100 Most Inspiring Leaders in the Life Sciences Industry
    Altasciences, a leading North American early phase contract research organization (CRO), is pleased to announce that, for a fourth consecutive year, CEO Chris Perkin has been honored as one of the 100 Most Inspiring Leaders in the Life Sciences Industry by PharmaVOICE magazine.
  • July 18, 2018
    Altasciences Participates in Clinical Trial for Type 1 Diabetes Mellitus
    Altasciences is pleased to have partnered with Xeris Pharmaceuticals, a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use, liquid-stable injectables, on a randomized, controlled, single blind, two-way crossover study to evaluate the efficacy and safety of their investigational glucagon injection in Type 1 diabetes mellitus (T1D) subjects in a state of insulin-induced hypoglycemia following baseline euglycemic steady-state.